Michael Rogers
Direktor/Vorstandsmitglied bei AKEBIA THERAPEUTICS, INC.
Vermögen: 141 152 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
John Butler | M | 59 | 11 Jahre | |
Jay Duker | M | 66 | 8 Jahre | |
Steven Gilman | M | 71 | 8 Jahre | |
Nancy Lurker | F | 66 | 8 Jahre | |
Göran Albert Ando | M | 75 | 6 Jahre | |
Michael Weiss | M | 58 | 11 Jahre | |
Myles Wolf | M | 53 | 4 Jahre | |
Cynthia Smith | F | 55 | 6 Jahre | |
Ron I. Honig | M | - | 6 Jahre | |
Ronald Frieson | M | 65 | 3 Jahre | |
John Landis | M | 71 | 6 Jahre | |
David Guyer | M | 64 | 5 Jahre | |
LeAnne Zumwalt | F | 65 | 3 Jahre | |
Adrian Adams | M | 73 | 6 Jahre | |
Christian Barnes | M | - | - | |
Maria Petrini | F | - | 1 Jahre | |
Mercedes Carrasco | F | - | - | |
Carolyn Rucci | F | - | 3 Jahre | |
Meredith Bowman | F | - | 2 Jahre | |
Tracey Vetterick | F | - | 2 Jahre | |
Jody Gould | M | - | 3 Jahre | |
Michael Rabinowitz | M | - | - | |
Steven Burke | M | 63 | 5 Jahre | |
Nicholas Grund | M | 54 | - | |
George Avgerinos | M | 71 | 11 Jahre | |
Leonard Dove | M | 51 | 2 Jahre | |
Richard Malabre | M | 63 | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Glenn L. Cooper | M | 71 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 20 Jahre |
Robyn Hunter | F | 62 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 14 Jahre |
Jodie Morrison | F | 48 | 4 Jahre | |
Michael Tarnok | M | 69 | 9 Jahre | |
Charles H. Abdalian | M | 73 | 1 Jahre | |
Regina Marek | F | 55 | 3 Jahre | |
Gregory Madison | M | 57 | 4 Jahre | |
Nicole Hadas | F | 51 | 11 Jahre | |
Michael Heffernan | M | 59 | 6 Jahre | |
Noah Beerman | M | 62 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 15 Jahre |
Bobby Sandage | M | 70 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 21 Jahre |
Mark Enyedy | M | 60 | 4 Jahre | |
Pieter Muntendam | M | 65 | 8 Jahre | |
David Mazzo | M | 67 | 15 Jahre | |
Harlan Weisman | M | 71 | 1 Jahre | |
Raymond Tabibiazar | M | 53 | - | |
Scott A. Holmes | M | 50 | 3 Jahre | |
Paul Ashton | M | 63 | 11 Jahre | |
Stéphane Bancel | M | 51 | 5 Jahre | |
Jason Amello | M | 55 | 7 Jahre | |
David Spellman | M | 48 | 3 Jahre | |
Lori Freedman | F | 57 | 10 Jahre | |
Robert Morales | M | 57 | 7 Jahre | |
Dale Ritter | M | 73 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 18 Jahre |
Daniel Paul Regan | M | 60 | 5 Jahre | |
Leonard S. Ross | M | 74 | 13 Jahre | |
Kristine Peterson | F | 64 | 3 Jahre | |
Michael Clayman | M | 72 | 4 Jahre | |
Amy Sullivan | F | 54 | 4 Jahre | |
Hong Guo | M | - | - | |
Kevin M. Jordan | M | - |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 2 Jahre |
Maxine Gowen | M | 66 | 7 Jahre | |
Adrian L. Rabinowicz | M | - | 6 Jahre | |
Eric Bouvier | M | 63 | 2 Jahre | |
Muneer Satter | M | 63 | 5 Jahre | |
Nancy Wysenski | F | 66 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | - |
Michel Dahan | M | 45 | 11 Jahre | |
Bruce R. Lakefield | M | 80 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | 4 Jahre |
Brian Adams | M | 50 | 4 Jahre | |
John Hohneker | M | 64 | 3 Jahre | |
Michael Wyzga | M | 69 | 4 Jahre | |
Dhaval Desai | M | - | 4 Jahre | |
Peter Savas | M | 75 | 8 Jahre | |
Eric Zhang | M | 43 | 5 Jahre | |
Rudy Howard | M | 67 | 2 Jahre | |
Violetta Cotreau | F | 51 | 2 Jahre | |
Marty Nazzaro | M | - | - | |
Wyche Fowler | M | 83 | 10 Jahre | |
Xiao Qin Lu | M | 49 | 5 Jahre | |
James Barry | M | 64 | 4 Jahre | |
Caroline B. Manogue | F | 55 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | - |
Ronald Renaud | M | 55 | 4 Jahre | |
David P. Holveck | M | 79 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | - |
Stephen Hoffman | M | 70 | 2 Jahre | |
Mark S. Butler | M | 77 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 16 Jahre |
Lora L. Pike | F | - | - | |
Thomas Forest Farb | M | 67 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 3 Jahre |
Brian Posner | M | 62 | 3 Jahre | |
David Barrett | M | 48 | - | |
Kevin Cameron | M | 64 | 11 Jahre | |
Ronald Eastman | M | 71 | 4 Jahre | |
Duane Nash | M | 53 | 5 Jahre | |
Gary Gemignani | M | 58 | 1 Jahre | |
Ellen Snow | F | - | 1 Jahre | |
Douglas Godshall | M | 59 | 9 Jahre | |
Tai Ching Ho | M | 62 | 3 Jahre | |
Amato Giaccia | M | 65 | 6 Jahre | |
Paul Hopper | M | 68 | 6 Jahre | |
Cheryl Cohen | F | 58 | 3 Jahre | |
Joseph Feczko | M | 75 | 6 Jahre | |
Sigurd Kirk | M | 57 | 3 Jahre | |
Scott Canute | M | 63 | 3 Jahre | |
Jack Kaye | M | 80 | 10 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 82 | 82,00% |
Australien | 18 | 18,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Rogers
- Persönliches Netzwerk